EBV-related post-transplant lymphoproliferative disorder

Clinical trials for EBV-related post-transplant lymphoproliferative disorder explained in plain language.

Never miss a new study

Get alerted when new EBV-related post-transplant lymphoproliferative disorder trials appear

Sign up with your email to follow new studies for EBV-related post-transplant lymphoproliferative disorder, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New combo therapy shows promise for kids with Transplant-Related cancer

Disease control Completed

This pilot study tested a combination of rituximab (a targeted antibody) and specially trained immune cells (LMP-specific T-cells) in 18 children who developed a type of lymphoma after receiving a solid organ transplant. The goal was to see if this approach could effectively trea…

Matched conditions: EBV-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER

Phase 2 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Jun 27, 2026 08:14 UTC

EBV-related post-transplant lymphoproliferative disorder

Get alerted when new EBV-related post-transplant lymphoproliferative disorder trials appear

New combo therapy shows promise for kids with Transplant-Related cancer